Citations for
1EMSY
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer
Dansonka-Mieszkowska A, Szafron LM, Moes-Sosnowska J, Kulinczak M, Balcerak A, Konopka B, Kulesza M, Budzilowska A, Lukasik M, Piekarska U, Rzepecka IK, Parada J, Zub R, Pienkowska-Grela B, Madry R, Siwicki JK, Kupryjanczyk J.
Oncotarget. Apr 3;9(25):17735-17755. doi: 10.18632/oncotarget.24878 2018
2EMSY, ZNF131
Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131
Mensinga A, Smits AH, Edupuganti RR, Baltissen MP, Jansen PW, Ter Hoeve N, van Weely DR, Poser I, van Diest PJ, Stunnenberg HG, Vermeulen M, Varier RA, Carrillo de Santa Pau E, van der Groep P, Lindeboom RG, Matarese F
J Biol Chem. Apr 1;291(14):7313-24. doi: 10.1074/jbc.M115.701227. Epub 2016 Feb 3. 2016
3EMSY
EMSY promoted the growth and migration of ovarian cancer cells.
Zhao X, Zhou Y, Nie M, Xian S, Chen H, Wen Y, Zhang L, Huang Y, Chen M, Wang S.
Tumour Biol. EMSY promoted the growth and migration of ovarian cancer cells. Tumour Biol. 2015 Apr;36(4):3085-92. doi: 10.1007/s13277-014-29 2015
4BRCA2, EMSY
The function of EMSY in cancer development
Hou J, Wang Z, Yang L, Guo X, Yang G.
Tumour Biol. Jun;35(6):5061-6. doi: 10.1007/s13277-013-1584-3. Epub 2014 Mar 9. 2014
5EMSY
Fine mapping of 11q13.5 identifies regions associated with prostate cancer and prostate cancer death
Nurminen R, Lehtonen R, Auvinen A, Tammela TL, Wahlfors T, Schleutker J.
Eur J Cancer. Oct;49(15):3335-43. doi: 10.1016/j.ejca.2013.06.006. Epub 2013 Jul 2. 2013
6RSF1, EMSY
Amplification of 11q13 in ovarian carcinoma.
Brown LA, Kalloger SE, Miller MA, Shih IeM, McKinney SE, Santos JL, Swenerton K, Spellman PT, Gray J, Gilks CB, Huntsman DG.
Genes Chromosomes Cancer 47(6):481-9. 2008
7EMSY
Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
Brown LA, Irving J, Parker R, Kim H, Press JZ, Longacre TA, Chia S, Magliocco A, Makretsov N, Gilks B, Pollack J, Huntsman D.
Gynecol Oncol 100(2):264-70. Epub 2005 Oct 19. 2006
8EMSY
Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.
Benusiglio PR, Lesueur F, Luccarini C, McIntosh J, Luben RN, Smith P, Dunning A, Easton DF, Ponder BA, Pharoah PD.
BMC Cancer 5:81. 2005
9BRCA2, EMSY
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.
Hughes-Davies L, Huntsman D, Ruas M, Fuks F, Bye J, Chin SF, Milner J, Brown LA, Hsu F, Gilks B, Nielsen T, Schulzer M, Chia S, Ragaz J, Cahn A, Linger L, Ozdag H, Cattaneo E, Jordanova ES, Schuuring E, Yu DS, Venkitaraman A, Ponder B, Doherty A, Aparicio S, Bentley D, Theillet C, Ponting CP, Caldas C, Kouzarides T.
Cell 115(5):523-35. 2003
10EMSY, LRRC32, RSF1, NDUFC2
HBXAP, a Novel PHD-Finger Protein, Possesses Transcription Repression Activity.
Shamay M, Barak O, Shaul Y.
Genomics 79(4):523-9. 2002